Statistics for Real-world data from the Portuguese Nivolumab Expanded Access Program (EAP) in previously treated Non Small Cell Lung Cancer (NSCLC).
Total visits
| views | |
|---|---|
| Real-world data from the Portuguese Nivolumab Expanded Access Program (EAP) in previously treated Non Small Cell Lung Cancer (NSCLC). | 90 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| Pulmonology. 2019.pdf(legacy) | 172 |
| Pulmonology. 2019.pdf | 12 |
Top country views
| views | |
|---|---|
| United States | 24 |
| Portugal | 23 |
| China | 14 |
| Australia | 11 |
| Canada | 5 |
| Ukraine | 4 |
| Mongolia | 3 |
| Argentina | 2 |
| Czechia | 1 |
| Germany | 1 |
| Latvia | 1 |
| Taiwan | 1 |